Hob Biotech collaborates with Roche Diagnostics in the field of chemiluminescent autoantibody detection productsZhitong·Oct 21, 2025 at 06:29 AM688656+2.56%
Hob Biotech: MM09 sublingual spray Phase III clinical trial completes enrollment of the first batch of subjectsZhitong·Sep 24, 2025 at 06:37 AM688656+2.56%
Hob Biotech released its semi-annual performance, with a net profit attributable to the parent company of 12.17 million yuan, a year-on-year decrease of 39.1%Zhitong·Aug 14, 2025 at 06:47 AM688656+2.56%
Hob Biotech plans to sell part of its land use rights and factory buildings for 19.52 million yuanZhitong·Aug 4, 2025 at 05:01 AM688656+2.56%
Medical device concept stocks continue to rise, Hob Biotech hits the 20% limit up in the afternoonZhitong·Jun 23, 2025 at 01:08 AM688656+2.56%603880+3.72%
The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limitZhitong·Jun 22, 2025 at 08:40 PM688399+10.09%603976+4.15%
The concept of innovative drugs surged and then fell back, with Hob Biotech dropping over 10%Zhitong·Jun 12, 2025 at 09:12 PM688197+1.26%688068+4.55%
Hob Biotech: The company's price-to-earnings ratio is significantly higher than the industry averageZhitong·Jun 12, 2025 at 05:12 AM688656+2.56%
Hob Biotech released its first-quarter results, with a net profit attributable to the parent company of 1.6392 million yuan, a year-on-year decrease of 56.97%Zhitong·Apr 28, 2025 at 04:55 AM688656+2.56%
Hob Biotech appointed Zhang Yangqing as Chief Financial OfficerZhitong·Apr 16, 2025 at 04:50 AM688656+2.56%
Hob Biotech released its 2024 annual performance, with a net profit attributable to the parent company of 36.8038 million yuan, a year-on-year decrease of 22.24%Zhitong·Mar 17, 2025 at 06:27 AM688656+2.56%
Hob Biotech's net profit for the year 2024 is 36.8469 million yuan, a year-on-year decrease of 22.15%Zhitong·Feb 26, 2025 at 04:01 AM688656+2.56%
Hob Biotech's subsidiary has obtained multiple medical device registration certificatesZhitong·Feb 24, 2025 at 02:21 AM688656+2.56%
Hob Biotech: The deadline for the tender offer has expired, and trading will resume on January 24Zhitong·Jan 23, 2025 at 05:59 AM688656+2.56%
